Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2)

被引:40
|
作者
Botta, A
Caldarola, S
Vallo, L
Bonifazi, E
Fruci, D
Gullotta, F
Massa, R
Novelli, G
Loreni, F [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Biol, Rome, Italy
[2] Univ Roma Tor Vergata, Dept Biopathol, Rome, Italy
[3] Bambino Gesu Pediat Hosp, Res Ctr, Rome, Italy
[4] Tor Vergata Hosp, Serv Med Genet, Rome, Italy
[5] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy
关键词
myotonic dystrophy; DM2; CCTG expansion; ZNF9; expression; splicing isoform;
D O I
10.1016/j.bbadis.2005.11.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myotonic dystrophy is caused by two different mutations: a (CTG)(n) expansion in 3' UTR region of the DMPK gene (DM1) and a (CCTG)(n) expansion in intron 1 of the ZNF9 gene (DM2). The most accredited mechanism for DM pathogenesis is an RNA gain-of-function. Other findings suggest a contributory role of DMPK-insufficiency in DM2. To address the issue of ZNF9 role in DM2. we have analyzed the effects of (CCTG)(n) expansion on ZNF9 expression in lymphoblastoid cell lines (n = 4) from DM2 patients. We did not observe any significant alteration in ZNF9 mRNA and protein levels, as shown by QRT-PCR and Western blot analyses. Additional RT-PCR experiments demonstrated that ZNF9 pre-mRNA splicing pattern, which includes two isoforms, is unmodified in DM2 cells. Our results indicate that the (CCTG)(n) expansion in the ZNF9 intron does not appear to have a direct consequence on the expression of the gene itself. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:329 / 334
页数:6
相关论文
共 50 条
  • [31] (CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis
    Yenigun, Vildan Betul
    Sirito, Mario
    Amcheslavky, Alla
    Czernuszewicz, Tomek
    Colonques-Bellmunt, Jordi
    Garcia-Alcover, Irma
    Wojciechowska, Marzena
    Bolduc, Clare
    Chen, Zhihong
    Lopez Castel, Arturo
    Krahe, Ralf
    Bergmann, Andreas
    [J]. DISEASE MODELS & MECHANISMS, 2017, 10 (08) : 993 - 1003
  • [32] Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland
    Suominen, Tiina
    Bachinski, Linda L.
    Auvinen, Satu
    Hackman, Peter
    Baggerly, Keith A.
    Angelini, Corrado
    Peltonen, Leena
    Krahe, Ralf
    Udd, Bjarne
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (07) : 776 - 782
  • [33] Differences in distribution and type of myotonic discharges in genetically confirmed myotonic dystrophy type 1 (DM1) versus type 2 (DM2)
    Logigian, E
    Ciafaloni, E
    Quinn, C
    Dilek, N
    Moxley, R
    Thornton, C
    [J]. NEUROLOGY, 2006, 66 (05) : A320 - A320
  • [34] Pattern of brain involvement myotonic dystrophy type 1 (DM1) versus type 2 (DM2)
    Angelini, Corrado
    Ferrati, Chiara
    Romeo, Vincenzo
    Ermani, Mario
    [J]. NEUROLOGY, 2008, 70 (11) : A306 - A306
  • [35] The parkinsonism-myotonic-myopathy-complex: Development of parkinsonism in a patient with myotonic dystrophy type 2 (DM2)
    Lolekha, P.
    Agarwal, P. A.
    McKeown, M. J.
    [J]. MOVEMENT DISORDERS, 2011, 26 : S341 - S341
  • [36] DM2 intronic expansions:: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression
    Margolis, Jamie M.
    Schoser, Benedikt G.
    Moseley, Melinda L.
    Day, John W.
    Ranum, Laura P. W.
    [J]. HUMAN MOLECULAR GENETICS, 2006, 15 (11) : 1808 - 1815
  • [37] Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2)
    Santoro, Massimo
    Modoni, Anna
    Masciullo, Marcella
    Gidaro, Teresa
    Broccolini, Aldobrando
    Ricci, Enzo
    Tonali, Pietro Attilio
    Silvestri, Gabriella
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2010, 89 (02) : 158 - 168
  • [38] Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene
    Sun, C.
    Van Ghelue, M.
    Tranebjaerg, L.
    Thyssen, F.
    Nilssen, O.
    Torbergsen, T.
    [J]. CLINICAL GENETICS, 2011, 80 (06) : 574 - 580
  • [39] Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2)
    Gaul, C.
    Schmidt, T.
    Windisch, G.
    Wieser, T.
    Mueller, T.
    Vielhaber, S.
    Zierz, S.
    Leplow, B.
    [J]. NEUROLOGY, 2006, 67 (02) : 350 - 352
  • [40] Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins:: A single shared haplotype indicates an ancestral founder effect
    Bachinski, LL
    Udd, B
    Meola, G
    Sansone, V
    Bassez, G
    Eymard, B
    Thornton, CA
    Moxley, RT
    Harper, PS
    Rogers, MT
    Jurkat-Rott, K
    Lehmann-Horn, F
    Wieser, T
    Gamez, J
    Navarro, C
    Bottani, A
    Kohler, A
    Shriver, MD
    Sallinen, R
    Wessman, M
    Zhang, SX
    Wright, FA
    Krahe, R
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (04) : 835 - 848